Regents of the University of California’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-117,315	Closed	-$2.63M	–	5
2024 Q2	$2.63M	Hold	117,315	–	–	1.44%	3
2024 Q1	$3.23M	Hold	117,315	–	–	0.94%	5
2023 Q4	$3.58M	Buy	117,315 +5,875	+5%	+$179K	0.45%	6
2023 Q3	$3.52M	Hold	111,440	–	–	0.45%	7
2023 Q2	$4.54M	Hold	111,440	–	–	0.57%	6
2023 Q1	$4.15M	Hold	111,440	–	–	0.77%	4
2022 Q4	$3.89M	Hold	111,440	–	–	0.74%	4
2022 Q3	$6.24M	Hold	111,440	–	–	1.26%	5
2022 Q2	$5.77M	Hold	111,440	–	–	1.16%	7
2022 Q1	$8.1M	Hold	111,440	–	–	1.22%	8
2021 Q4	$13.2M	Hold	111,440	–	–	1.85%	7
2021 Q3	$15M	Hold	111,440	–	–	1.76%	8
2021 Q2	$18M	Hold	111,440	–	–	2.3%	7
2021 Q1	$8.94M	Hold	111,440	–	–	1.17%	8
2020 Q4	$6.06M	Hold	111,440	–	–	0.88%	7
2020 Q3	$2.22M	Hold	111,440	–	–	0.31%	9
2020 Q2	$2.34M	Hold	111,440	–	–	0.33%	10
2020 Q1	$1.36M	Hold	111,440	–	–	0.2%	11
2019 Q4	$1.64M	Hold	111,440	–	–	0.86%	13
2019 Q3	$1.49M	Hold	111,440	–	–	2.85%	9
2019 Q2	$1.82M	Sell	111,440 -412,983	-79%	-$6.76M	5.15%	6
2019 Q1	$11.1M	Hold	524,423	–	–	26.04%	1
2018 Q4	$7.16M	Hold	524,423	–	–	17.31%	1
2018 Q3	$15M	Hold	524,423	–	–	29.21%	1
2018 Q2	$14.3M	Hold	524,423	–	–	37.54%	1
2018 Q1	$11.1M	Hold	524,423	–	–	20.27%	2
2017 Q4	$10.1M	Buy	+524,423	New	+$10.1M	15.19%	2